GMO (Jeremy Grantham)
GMO (Jeremy Grantham) (Grantham, Mayo, Van Otterloo & Co. LLC) reported 663 positions worth $44.40B as of June 30, 2026 (13F filed August 13, 2026). Largest holding: MSFT (5.7%).
| # | Symbol | Company | Type | Value ↓ | % Port. | Time Held | Shares | 1Y | YTD |
|---|---|---|---|---|---|---|---|---|---|
| ▸ 1 | MSFT | SH | $2.54B | 5.73% | >10 Years | 6,816,326 | — | — | |
| ▸ 2 | LRCX | SH | $2.37B | 5.33% | 1.8 Years | 5,464,726 | — | — | |
| ▸ 3 | GOOGL | SH | $2.19B | 4.94% | >10 Years | 6,132,636 | — | — | |
| ▸ 4 | AAPL | SH | $1.98B | 4.46% | >10 Years | 6,848,782 | — | — | |
| ▸ 5 | META | SH | $1.94B | 4.37% | 8.5 Years | 3,446,717 | — | — | |
| ▸ 6 | JNJ | SH | $1.81B | 4.07% | >10 Years | 7,110,133 | — | — | |
| ▸ 7 | AMZN | SH | $1.46B | 3.29% | 8 Years | 6,136,926 | — | — | |
| ▸ 8 | TXN | SH | $1.39B | 3.14% | >10 Years | 4,674,406 | — | — | |
| ▸ 9 | TMO | SH | $1.37B | 3.09% | 2.3 Years | 2,739,191 | — | — | |
| ▸ 10 | AVGO | SH | $1.23B | 2.78% | 5.5 Years | 3,267,040 | — | — |
The free plan shows the top 10 positions. The remaining 653 positions, the full portfolio and quarter changes unlock with Pro.
Pro Feature
This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.
Upgrade to ProRelated managers
Five closest superinvestors by Jaccard overlap of tickers held in the latest quarter (computed nightly).
| Manager | Overlap | Shared holdings |
|---|---|---|
| Bridgewater Associates (Ray Dalio) | 23.8% | BTI, BF-B, CI, CVS, CAT, CVX, C, KO +108 |
| Citadel Advisors (Ken Griffin) | 22.4% | BMY, BTI, CI, CVS, CAT, CVX, C, KO +135 |
| Two Sigma Investments | 20.9% | BMY, BTI, CI, CM, CAT, CVX, C, KO +127 |
| Capital Research Global Investors | 20.7% | BTI, CI, CVS, CAT, CVX, KO, CTSH, GE +66 |
| D.E. Shaw & Co | 20.7% | BMY, BTI, CI, CVS, CAT, CVX, C, KO +109 |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does GMO (Jeremy Grantham) hold as of Q2 2026?
GMO (Jeremy Grantham) reported 663 positions worth $44.40B in its Q2 2026 13F filing. Largest positions: MSFT (5.7%), LRCX (5.3%), GOOGL (4.9%), AAPL (4.5%) and META (4.4%).
What did GMO (Jeremy Grantham) buy in Q2 2026?
No previous quarter is available yet; the comparison appears with the next filing.
What did GMO (Jeremy Grantham) sell in Q2 2026?
No previous quarter is available yet.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.